Dihydroartemisinin enhances the inhibitory effect of sorafenib on HepG2 cells by inducing ferroptosis and inhibiting energy metabolism
Fatigue, lightheadedness, and low mood can reflect the calorie deficit rather than the drug itself
R., Cox, L., Tomayko, K., and Treadwell, B
Every time I open Instagram, I see an ad from a telehealth provider pushing GLP-1s from this new angle: Lose those last five, 10, 15 pounds! Try an extra-low dose! These companies are saying out loud what some of us have long suspected: Aesthetic weight-loss goals, rather than health needs, are the motivating factor for a number of people interested in taking GLP-1s